OrbiMed Capital GP IV LLC — SEC Form 4 filings
SEC reporting owner CIK 1502240. 1 Form 4 filing on record with FilingPulse; latest filed 2024-07-02.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2024-07-02 to 2024-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 428,300 shares, $2,022,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 378,000 shares @ $4.74 ($1,791,720) in TELA Bio, Inc., filed 2024-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | 10% owner | 1 | — | 3 legs · 428,300 sh · $2,022,000 | — |
Form 4 filings — OrbiMed Capital GP IV LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-02 | 4 | TELA Bio, Inc. (TELA) jointly with ORBIMED ADVISORS LLC | Sale (S): 378,000 @ $4.74 · Sale (S): 13,700 @ $4.68 · Sale (S): 36,600 @ $4.54 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1502240 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →